Abstract
We report a case of primary cutaneous aspergillosis in an immunocompetent child that responded rapidly to oral voriconazole therapy. Voriconazole may be considered as a treatment option for pediatric patients with primary cutaneous aspergillosis.
Original language | English (US) |
---|---|
Pages (from-to) | 493-495 |
Number of pages | 3 |
Journal | Pediatric Dermatology |
Volume | 26 |
Issue number | 4 |
DOIs | |
State | Published - Jul 2009 |
Externally published | Yes |
ASJC Scopus subject areas
- Dermatology
- Pediatrics, Perinatology, and Child Health